These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36896797)

  • 1. Guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis: a 2-year randomized controlled trial with a naturalistic cohort.
    Liu CC; Hsieh MH; Chien YL; Liu CM; Lin YT; Hwang TJ; Hwu HG
    Psychol Med; 2023 Nov; 53(15):7078-7086. PubMed ID: 36896797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol of guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis based on pragmatic design.
    Liu CC; Hsieh MH; Chien YL; Liu CM; Lin YT; Hwang TJ; Hwu HG
    Early Interv Psychiatry; 2022 Feb; 16(2):178-185. PubMed ID: 33751764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-tapering trajectories in patients with remitted psychosis undergoing guided antipsychotic reduction to reach minimum effective dose.
    Liu CC; Hsieh MH; Chien YL; Liu CM; Lin YT; Hwang TJ; Hwu HG
    Eur Psychiatry; 2023 Aug; 66(1):e66. PubMed ID: 37578111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
    J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm.
    Liu CC; Takeuchi H
    CNS Drugs; 2020 Feb; 34(2):117-126. PubMed ID: 31741178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol.
    Weller A; Gleeson J; Alvarez-Jimenez M; McGorry P; Nelson B; Allott K; Bendall S; Bartholomeusz C; Koval P; Harrigan S; O'Donoghue B; Fornito A; Pantelis C; Paul Amminger G; Ratheesh A; Polari A; Wood SJ; van der El K; Ellinghaus C; Gates J; O'Connell J; Mueller M; Wunderink L; Killackey E
    Early Interv Psychiatry; 2019 Dec; 13(6):1345-1356. PubMed ID: 30488637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.
    Wunderink L; Nieboer RM; Wiersma D; Sytema S; Nienhuis FJ
    JAMA Psychiatry; 2013 Sep; 70(9):913-20. PubMed ID: 23824214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
    Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
    Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome.
    Wunderink L; Nienhuis FJ; Sytema S; Slooff CJ; Knegtering R; Wiersma D
    J Clin Psychiatry; 2007 May; 68(5):654-61. PubMed ID: 17503973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of discontinuation v. maintenance of antipsychotic medication on relapse rates in patients with remitted/stable first-episode psychosis: a meta-analysis.
    Kishi T; Ikuta T; Matsui Y; Inada K; Matsuda Y; Mishima K; Iwata N
    Psychol Med; 2019 Apr; 49(5):772-779. PubMed ID: 29909790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.
    Alvarez-Jimenez M; O'Donoghue B; Thompson A; Gleeson JF; Bendall S; Gonzalez-Blanch C; Killackey E; Wunderink L; McGorry PD
    CNS Drugs; 2016 May; 30(5):357-68. PubMed ID: 27106296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to Gradual Dose Reduction of Chronic Off-Label Antipsychotics Used for Behavioral and Psychological Symptoms of Dementia.
    Tjia J; Reidenberg MM; Hunnicutt JN; Paice K; Donovan JL; Kanaan A; Briesacher BA; Lapane KL
    Consult Pharm; 2015 Oct; 30(10):599-611. PubMed ID: 26450142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia. A Meta-Analysis of Randomized Controlled Trials.
    Bogers JPAM; Hambarian G; Walburgh Schmidt N; Vermeulen JM; de Haan L
    Schizophr Bull; 2023 Jan; 49(1):11-23. PubMed ID: 36200866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse rates following antipsychotic discontinuation in the maintenance phase after first-episode of schizophrenia: Results of a long-term follow-up study.
    Üçok A; Kara İA
    Schizophr Res; 2020 Nov; 225():31-38. PubMed ID: 31653578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis.
    Ostuzzi G; Vita G; Bertolini F; Tedeschi F; De Luca B; Gastaldon C; Nosé M; Papola D; Purgato M; Del Giovane C; Correll CU; Barbui C
    Lancet Psychiatry; 2022 Aug; 9(8):614-624. PubMed ID: 35753323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia- a case series.
    Mølgaard SN; Nielsen MØ; Roed K; Nielsen J
    BMC Psychiatry; 2024 Mar; 24(1):240. PubMed ID: 38553687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-year effects of antipsychotics in schizophrenia and affective psychotic disorders.
    Harrow M; Jobe TH; Tong L
    Psychol Med; 2022 Oct; 52(13):2681-2691. PubMed ID: 33550993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.